secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Teknova, Inc. (TKNO)
CIK:        0001850902
Form:       8-K
Filed at:   2026-08-05T20:06:41+00:00
Accession:  0001193125-26-335059
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teknova Q2 revenue $12.2M (+18% YoY); raises FY 2026 guidance to $45-47M
------------------------------------------------------------------------

- Q2 2026 revenue $12.2M, up 18% from $10.3M in Q2 2025; net loss narrowed to $3.2M ($0.06 loss per share).
- Lab Essentials revenue $9.2M (+18% YoY); Clinical Solutions $2.4M (+18% YoY).
- Gross margin improved to 40.1% from 38.7%; Free Cash Outflow reduced to $0.6M from $2.3M.
- FY 2026 revenue guidance raised to $45-47M; Free Cash Outflow expected <$8M.
- Launched AI-powered Build-Tek custom order configurator for faster preclinical-to-clinical manufacturing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850902/000119312526335059/0001193125-26-335059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850902/000119312526335059/tkno-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-335059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer